Co-delivery of chlorin e6 and doxorubicin using PEGylated hollow nanocapsules for ‘all-in-one’ tumor theranostics

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Torre LA, Bray F, Siegel RL et al. Global cancer statistics. 2012. CA Cancer J. Clin. 65(2), 87–108 (2015).
  MedlineGoogle Scholar
• 2. Holohan C, Van Schaeybroeck S, Longley DB et al. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 13(10), 714–726 (2013).
  Medline CASGoogle Scholar
• 3. Housman G, Byler S, Heerboth S et al. Drug resistance in cancer: an overview. Cancers 6(3), 1769–1792 (2014).
  Medline CASGoogle Scholar
• 4. Zahreddine H, Borden KLB. Mechanisms and insights into drug resistance in cancer. Front. Pharmacol. 4, 28 (2013).
  MedlineGoogle Scholar
• 5. Tang Y, Wang Y, Kiani MF et al. Classification, treatment strategy, and associated drug resistance in breast cancer. Clin. Breast Cancer 16(5), 335–343 (2016).
  MedlineGoogle Scholar
• 6. Miller KD, Siegel RL, Lin CC et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J. Clin. 66(4), 271–289 (2016). • Illustrates current information of therapeutic modalities and treatment-related side effects of cancer.
  MedlineGoogle Scholar
• 7. Feng Y, Jonker MJ, Moustakas I et al. Dynamics of mutations during development of resistance by Pseudomonas aeruginosa against five antibiotics. Antimicrob. Agents Chemother. 60(7), 4229–4236 (2016).
  Medline CASGoogle Scholar
• 8. Luqmani YA. Mechanisms of drug resistance in cancer chemotherapy. Med. Prin. Pract. 14(Suppl. 1), 35–48 (2005).
  MedlineGoogle Scholar
• 9. Lotfi-Jam K, Carey M, Jefford M et al. Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J. Clin. Oncol. 26(34), 5618–5629 (2008).
  MedlineGoogle Scholar
• 10. Perez-Herrero E, Fernandez-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur. J. Pharm. Biopharm. 93, 52–79 (2015). •• Illustrates the recent advances in functional nanomedicines for on-target transporting chemotherapeutic drugs.
  Medline CASGoogle Scholar
• 11. Bahrami B, Hojjat-Farsangi M, Mohammadi H et al. Nanoparticles and targeted drug delivery in cancer therapy. Immunol. Lett. 190, 64–83 (2017).
  Medline CASGoogle Scholar
• 12. Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 86(3), 215–223 (2009).
  Medline CASGoogle Scholar
• 13. Jaque D, Maestro LM, del Rosal B et al. Nanoparticles for photothermal therapies. Nanoscale 6(16), 9494–9530 (2014).
  Medline CASGoogle Scholar
• 14. Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy. Chem. Rev. 115(4), 1990–2042 (2015).
  Medline CASGoogle Scholar
• 15. Revia RA, Zhang M. Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances. Mater. Today 19(3), 157–168 (2016).
  Medline CASGoogle Scholar
• 16. Wood AK, Sehgal CM. A review of low-intensity ultrasound for cancer therapy. Ultrasound Med. Biol. 41(4), 905–928 (2015).
  MedlineGoogle Scholar
• 17. Linsley CS, Wu BM. Recent advances in light-responsive on-demand drug-delivery systems. Ther. Deliv. 8(2), 89–107 (2017). •• Illustrates the most recent studies on light-activable on-damand drug delivery for disease management.
  Medline CASGoogle Scholar
• 18. Chin AL, Zhong Y, Tong R. Emerging strategies in near-infrared light triggered drug delivery using organic nanomaterials. Biomater. Sci. 5(8), 1491–1499 (2017).
  Medline CASGoogle Scholar
• 19. Shibu ES, Hamada M, Murase N et al. Nanomaterials formulations for photothermal and photodynamic therapy of cancer. J. Photochemem. Photobiol. C 15, 53–72 (2013).
  CASGoogle Scholar
• 20. Onal ED, Guven K. Plasmonic photothermal therapy in third and fourth biological windows. J. Phys. Chem. C 121(1), 684–690 (2017).
  CASGoogle Scholar
• 21. Zou LL, Wang H, He B et al. Current approaches of photothermal therapy in treating cancer metastasis with nanotherapeutics. Theranostics 6(6), 762–72 (2016).
  Medline CASGoogle Scholar
• 22. Huang Z. A review of progress in clinical photodynamic therapy. Technol. Cancer Res. Treat. 4(3), 283–293 (2005).
  Medline CASGoogle Scholar
• 23. Saini R, Poh CF. Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders. Oral Dis. 19(5), 440–451 (2013).
  Medline CASGoogle Scholar
• 24. Yan F, Wu H, Liu HM et al. Molecular imaging-guided photothermal/photodynamic therapy against tumor by iRGD-modified indocyanine green nanoparticles. J. Control. Rel. 224, 217–228 (2016). •• Illustrates a typical example of combined photothermal and photodynamic therapy using iRGD-modified indocyanine green nanoparticles.
  Medline CASGoogle Scholar
• 25. Guo M, Mao H, Li Y et al. Dual imaging-guided photothermal/photodynamic therapy using micelles. Biomaterials 35(16), 4656–4666 (2014).
  Medline CASGoogle Scholar
• 26. Park H, Yang J, Lee J et al. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. ACS Nano 3(10), 2919–2926 (2009).
  Medline CASGoogle Scholar
• 27. Xiao ZY, Ji CW, Shi JJ et al. DNA self-assembly of targeted near-infrared-responsive gold nanoparticles for cancer thermo-chemotherapy. Angew. Chem. Int. Ed. 51(47), 11853–11857 (2012).
  Medline CASGoogle Scholar
• 28. Hribar KC, Lee MH, Lee D et al. Enhanced release of small molecules from near-infrared light responsive polymer–nanorod composites. ACS Nano 5(4), 2948–2956 (2011).
  Medline CASGoogle Scholar
• 29. Bao ZH, Liu XR, Liu YD et al. Near-infrared light-responsive inorganic nanomaterials for photothermal therapy. Asian J. Pharm. Sci. 11(3), 349–364 (2016).
  Google Scholar
• 30. Song XJ, Chen Q, Liu Z. Recent advances in the development of organic photothermal nano-agents. Nano Res. 8(2), 340–354 (2015).
  CASGoogle Scholar
• 31. Li YB, Lu W, Huang QA et al. Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine (Lond.) 5(8), 1161–1171 (2010).
  CASGoogle Scholar
• 32. Wang SH, Riedinger A, Li HB et al. Plasmonic copper sulfide nanocrystals exhibiting near-infrared photothermal and photodynamic therapeutic effects. ACS Nano 9(2), 1788–1800 (2015).
  Medline CASGoogle Scholar
• 33. Kundu J, Pradhan D. Controlled synthesis and catalytic activity of copper sulfide nanostructured assemblies with different morphologies. ACS Appl. Mater. Inter. 6(3), 1823–1834 (2014).
  Medline CASGoogle Scholar
• 34. Guo L, Panderi I, Yan DD et al. A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity. ACS Nano 7(10), 8780–8793 (2013).
  Medline CASGoogle Scholar
• 35. Ramadan S, Guo LR, Li YJ et al. Hollow copper sulfide nanoparticle-mediated transdermal drug delivery. Small 8(20), 3143–3150 (2012).
  Medline CASGoogle Scholar
• 36. Han L, Zhang Y, Chen XW et al. Protein-modified hollow copper sulfide nanoparticles carrying indocyanine green for photothermal and photodynamic therapy. J. Mater. Chem. B 4(1), 105–112 (2016). •• Demonstrates a great potential of using hollow CuS nanoparticles for syngistic therapy of cancer.
  CASGoogle Scholar
• 37. Liu Y, Ma K, Jiao T et al. Water-insoluble photosensitizer nanocolloids stabilized by supramolecular interfacial assembly towards photodynamic therapy. Sci. Rep. 7, 42978 (2017).
  Medline CASGoogle Scholar
• 38. Kostenich GA, Zhuravkin IN, Zhavrid EA. Experimental grounds for using chlorin e6 in the photodynamic therapy of malignant tumors. J. Photochem. Photobio. B 22(3), 211–217 (1994).
  Medline CASGoogle Scholar
• 39. Zhang C, Cheng X, Chen M et al. Fluorescence guided photothermal/photodynamic ablation of tumours using pH-responsive chlorin e6-conjugated gold nanorods. Colloid Surf. B 160, 345–354 (2017).
  Medline CASGoogle Scholar
• 40. Dong K, Liu Z, Li ZH et al. Hydrophobic anticancer drug delivery by a 980 nm laser-driven photothermal vehicle for efficient synergistic therapy of cancer cells in vivo. Adv. Mater. 25(32), 4452–4458 (2013). • Illustrates a feasible strategy to synthesis hollow CuS nanoparticles through ion-exchanging process.
  Medline CASGoogle Scholar
• 41. Wang BK, Wang JH, Liu Q et al. Rose–bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies. Biomaterials 35(6), 1954–1966 (2014).
  Medline CASGoogle Scholar
• 42. Tian Q, Jiang F, Zou R et al. Hydrophilic Cu₉S₅ nanocrystals: a photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo. ACS Nano 5(12), 9761–9771 (2011).
  Medline CASGoogle Scholar
• 43. Yin W, Yan L, Yu J et al. High-throughput synthesis of single-layer MoS₂ nanosheets as a near-infrared photothermal-triggered drug delivery for effective cancer therapy. ACS Nano 8(7), 6922–6933 (2014).
  Medline CASGoogle Scholar
• 44. Sareen S, Mathew G, Joseph L. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int. J. pharm. Invest. 2(1), 12–17 (2012).
  Medline CASGoogle Scholar
• 45. Yan F, Duan W, Li Y et al. NIR-laser-controlled drug release from DOX/IR-780-loaded temperature-sensitive-liposomes for chemo-photothermal synergistic tumor therapy. Theranostics 6(13), 2337–2351 (2016).
  Medline CASGoogle Scholar
• 46. Ma Y, Liang X, Tong S et al. Gold nanoshell nanomicelles for potential magnetic resonance imaging, light-triggered drug release, and photothermal therapy. Adv. Funct. Mater. 23(7), 815–822 (2013).
  CASGoogle Scholar
• 47. Xing RJ, Bhirde AA, Wang SJ et al. Hollow iron oxide nanoparticles as multidrug resistant drug delivery and imaging vehicles. Nano Res. 6(1), 1–9 (2013).
  CASGoogle Scholar
• 48. Luo W, Liu RS, Zhu JG et al. Subcellular location and photodynamic therapeutic effect of chlorin e6 in the human tongue squamous cell cancer Tca8113 cell line. Oncol. Lett. 9(2), 551–556 (2015).
  MedlineGoogle Scholar
• 49. Yang L, Wang ZR, Wang J et al. Doxorubicin conjugated functionalizable carbon dots for nucleus targeted delivery and enhanced therapeutic efficacy. Nanoscale 8(12), 6801–6809 (2016).
  Medline CASGoogle Scholar
• 50. Oh N, Park JH. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int. J. Nanomed. 9(Suppl. 1), 51–63 (2014).
  MedlineGoogle Scholar
• 51. Wang J, Deng X, Zhang F et al. ZnO nanoparticle-induced oxidative stress triggers apoptosis by activating JNK signaling pathway in cultured primary astrocytes. Nanoscale Res. Lett. 9(1), 117 (2014).
  MedlineGoogle Scholar
• 52. Sazgarnia A, Shanei A, Taheri AR et al. Therapeutic effects of acoustic cavitation in the presence of gold nanoparticles on a colon tumor model. J. Ultras. Med. 32(3), 475–483 (2013).
  MedlineGoogle Scholar
• 53. Kobayashi H, Watanabe R, Choyke PL. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics 4(1), 81–89 (2013).
  MedlineGoogle Scholar
• 54. Yang G, Xu L, Chao Y et al. Hollow MnO₂ as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. Nat. Commun. 8(1), 902 (2017).
  MedlineGoogle Scholar
• 55. Guo LR, Panderi I, Yan DD et al. A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity. ACS Nano 7(10), 8780–8793 (2013).
  Medline CASGoogle Scholar